Loading...
Please wait, while we are loading the content...
Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis
| Content Provider | Semantic Scholar |
|---|---|
| Author | Duffy, Joseph Pittlekow, Mark R. Kolbert, Christopher P. Rutledge, Barbara J. Persing, David H. |
| Copyright Year | 1997 |
| Abstract | words, we treated patients with less severe liver damage and lower viral load, while subjects with more severe histological and virological disease, but normal liver biochemistry, could not be offered antiviral treatment. We have tried to explain the current thinking to our patients and to their practitioners, but we are aware that we created more questions than answers. What should we treat: the disease (liver damage, viral infection) or the test (ALT)? |
| File Format | PDF HTM / HTML |
| DOI | 10.1016/S0140-6736(97)80017-7 |
| PubMed reference number | 9033471 |
| Journal | Medline |
| Volume Number | 349 |
| Alternate Webpage(s) | https://api.elsevier.com/content/article/pii/S0140673697800177 |
| Alternate Webpage(s) | https://www.sciencedirect.com/science/article/pii/S0140673697800177?dgcid=api_sd_search-api-endpoint |
| Alternate Webpage(s) | https://doi.org/10.1016/S0140-6736%2897%2980017-7 |
| Journal | The Lancet |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |